The European Union's Health Check: Uncovering Challenges and Opportunities
The European health landscape is undergoing a profound transformation, and a recent report reveals both encouraging progress and critical issues.
A collaborative effort by the European Observatory on Health Systems and Policies, the Organisation for Economic Co-operation and Development, and the European Commission has unveiled the latest edition of the Country Health Profiles, offering a comprehensive snapshot of healthcare across the EU, Iceland, and Norway.
Unveiling the State of European Healthcare:
These profiles provide a treasure trove of insights, allowing policymakers and the public to compare countries across various health indicators. From population health to risk factors, healthcare performance, and pharmaceutical trends, the interactive dashboard (https://eurohealthobservatory.who.int/publications/country-health-profiles/soheu2025/interactive-dashboard-2025) paints a detailed picture of Europe's health status.
Policy Trends and Noncommunicable Diseases:
The accompanying Synthesis Report (https://eurohealthobservatory.who.int/publications/country-health-profiles/soheu2025/synthesis-report-2025) sheds light on the policy landscape, emphasizing the battle against noncommunicable diseases. These diseases, such as heart disease and cancer, continue to be the primary cause of preventable deaths in the EU, with an estimated 2.4 million years of productive life lost in 2022.
But here's where it gets controversial: While member states are taking action, targeting risk factors like tobacco, alcohol, and obesity, the report hints at a potential debate. Are these measures enough, or should we be doing more to tackle the root causes of these diseases?
Primary Care in the Spotlight:
Primary care is under strain across the EU. With an aging population and historical underinvestment, the demand for primary care services is outpacing the supply. The report highlights the imbalance in the healthcare workforce, with a shortage of general practitioners and a growing need for integrated care models.
Pharmaceutical Spending: A Rising Concern:
Pharmaceutical expenditure is another area of concern. Medicine costs have been rising, contributing to 60% of pharmaceutical spending and 13% of overall health expenditure in the EU in 2023. Countries have responded with policy reforms to enhance access and affordability, but the challenge remains, especially with the introduction of costly new treatments.
Digital Health's Rise:
The COVID pandemic accelerated the digital transformation of healthcare in the EU. Investment in health technologies has surged, and electronic health records are now widely accessible. By the end of 2024, all EU member states had implemented electronic health record services, with most countries ensuring access for the majority of their populations.
Spain's Health Story:
Spain's health profile is a tale of resilience and challenges. With a life expectancy of 84 years in 2024, Spain boasts impressive health outcomes. However, it faces issues like high smoking rates (although declining) and rising alcohol consumption. Health expenditure per capita is lower than the EU average, but Spain has made strides in reducing preventable deaths.
Pharmaceutical Spending Paradox:
Interestingly, Spain's spending on retail pharmaceuticals is below the EU average, but expenditures on hospital-dispensed medicines are rising rapidly. This shift raises questions about the accessibility and affordability of specialized treatments and the potential impact on overall healthcare costs.
Workforce Imbalances:
Spain's healthcare workforce is characterized by a relatively high number of physicians and a lower number of nurses. While the country has more family physicians than the EU average, it faces a projected shortage of specialists, including geriatricians, psychiatrists, and radiologists. This imbalance underscores the need for strategic workforce planning.
The Bigger Picture:
This report provides a comprehensive overview of the EU's health systems, revealing both successes and areas for improvement. It invites discussion on the effectiveness of current policies and the need for innovative solutions to address long-standing challenges. Are we doing enough to prevent noncommunicable diseases? How can we ensure equitable access to healthcare and pharmaceuticals? These questions are left for the audience to ponder and discuss.
